Literature DB >> 2462155

Punta Toro virus infection of C57BL/6J mice: a model for phlebovirus-induced disease.

D Y Pifat1, J F Smith.   

Abstract

Punta Toro virus infections of inbred strains of mice have been characterized and evaluated as a model in which to study various aspects of the host response to phlebovirus infections and the requirements for protective immunity. The Adames strain of Punta Toro virus was found to be strongly hepatotropic and lymphotropic and the outcome of infection was largely a function of age. C57BL/6J mice of less than 5 weeks of age uniformly developed fulminant hepatocellular necrosis with mean survival times of 4.2 days. Resistance to lethal infection increased with age such that greater than 95% of 8-week-old mice survived challenge. The kinetics of viremia, antibody production, and hematological changes in 4- and 8-week animals indicated that the survival of the older animals is related to their ability to delay virus replication and the development of hepatic lesions during the initial 48 h of infection and their ability to terminate virus replication and clear virus from the circulation 4 to 5 days after infection. The mechanisms responsible for this resistance were studied using anti-interferon serum, immunosuppression, and passive immunization.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2462155     DOI: 10.1016/0882-4010(87)90011-8

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  21 in total

1.  Pathogenesis of emerging severe fever with thrombocytopenia syndrome virus in C57/BL6 mouse model.

Authors:  Cong Jin; Mifang Liang; Junyu Ning; Wen Gu; Hong Jiang; Wei Wu; Fushun Zhang; Chuan Li; Quanfu Zhang; Hua Zhu; Ting Chen; Ying Han; Weilun Zhang; Shuo Zhang; Qin Wang; Lina Sun; Qinzhi Liu; Jiandong Li; Tao Wang; Qiang Wei; Shiwen Wang; Ying Deng; Chuan Qin; Dexin Li
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-04       Impact factor: 11.205

2.  Recombinant Eimeria protozoan protein elicits resistance to acute phlebovirus infection in mice but not hamsters.

Authors:  Brian B Gowen; Donald F Smee; Min-Hui Wong; John W Judge; Kie-Hoon Jung; Kevin W Bailey; Anne M Pace; Barnett Rosenberg; Robert W Sidwell
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

Review 3.  Hemorrhagic fever of bunyavirus etiology: disease models and progress towards new therapies.

Authors:  Brian B Gowen; Brady T Hickerson
Journal:  J Microbiol       Date:  2017-02-28       Impact factor: 3.422

4.  Attenuation of pathogenic Rift Valley fever virus strain through the chimeric S-segment encoding sandfly fever phlebovirus NSs or a dominant-negative PKR.

Authors:  Shoko Nishiyama; Olga A L Slack; Nandadeva Lokugamage; Terence E Hill; Terry L Juelich; Lihong Zhang; Jennifer K Smith; David Perez; Bin Gong; Alexander N Freiberg; Tetsuro Ikegami
Journal:  Virulence       Date:  2016-06-01       Impact factor: 5.882

5.  The S segment of Punta Toro virus (Bunyaviridae, Phlebovirus) is a major determinant of lethality in the Syrian hamster and codes for a type I interferon antagonist.

Authors:  Lucy A Perrone; Krishna Narayanan; Melissa Worthy; C J Peters
Journal:  J Virol       Date:  2006-10-18       Impact factor: 5.103

6.  Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment.

Authors:  Dionna Scharton; Kevin W Bailey; Zachary Vest; Jonna B Westover; Yohichi Kumaki; Arnaud Van Wettere; Yousuke Furuta; Brian B Gowen
Journal:  Antiviral Res       Date:  2014-01-31       Impact factor: 5.970

7.  Punta Toro virus (Bunyaviridae, Phlebovirus) infection in mice: strain differences in pathogenesis and host interferon response.

Authors:  Michelle Mendenhall; Min-Hui Wong; Ramona Skirpstunas; John D Morrey; Brian B Gowen
Journal:  Virology       Date:  2009-09-26       Impact factor: 3.616

8.  Efficacy of favipiravir (T-705) and T-1106 pyrazine derivatives in phlebovirus disease models.

Authors:  Brian B Gowen; Min-Hui Wong; Kie-Hoon Jung; Donald F Smee; John D Morrey; Yousuke Furuta
Journal:  Antiviral Res       Date:  2009-10-27       Impact factor: 5.970

9.  Effect of macrophage source and activation on susceptibility in an age-dependent model of murine hepatitis caused by a phlebovirus, Punta Toro.

Authors:  P S Latham; S B Sepelak
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

10.  Prophylaxis with cationic liposome-DNA complexes protects hamsters from phleboviral disease: importance of liposomal delivery and CpG motifs.

Authors:  Brian B Gowen; Jeff Fairman; Steven Dow; Ryan Troyer; Min-Hui Wong; Kie-Hoon Jung; Peter C Melby; John D Morrey
Journal:  Antiviral Res       Date:  2008-10-07       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.